Marmoleum flooring from Forbo is fast becoming a powerful weapon worldwide in the fight against the spread of bacteria such as MRSA (Methicillin-Resistant Staphyloccus Aureus), which continues to be an ongoing problem in healthcare facilities.

Supporting this is the release of the results of a major study. Undertaken by Curtis Gemmel, Professor of Bacterial Infection and Epidemiology at the University of Glasgow, the study confirmed that Marmoleum does completely inhibit the growth of the MRSA superbug.

Professor Gemmel tested Marmoleum under “worst case conditions” and found the results provided “the most robust case for using Marmoleum as an ally in the fight against infection”.

His tests established that Marmoleum inhibited the growth of MRSA and, except in the most extreme laboratory testing conditions, even killed the superbug.

It found that Staphylococcus aureus, including MRSA strains commonly associated with hospital acquired infection, were less likely to survive, reducing the risk of these bacteria spreading.

Professor Gemmel had been skeptical about Marmoleum’s antibacterial qualities before tests started at the TNO laboratory in Holland. Further details are available at

Independent tests also confirmed that Marmoleum’s two-layer ‘Topshield’ surface finish, made from tough high density primer, creates a more hygienic environment and reduces maintenance costs.

Topshield is resistant to scuffing and scratching and helps to ensure Marmoleum, made from natural raw materials, is built to withstand the most demanding healthcare environments.

Available in sheets and tile formats in more than 100 colours and six design effects, Marmoleum flooring is a stylish addition to any healthcare institution. Design elements can be cut to chosen colour specifications or a hospital logo, signage or custom design incorporated into the floor for a stand-out effect.

For further information contact Forbo Flooring on 1800 22 44 71, email:,